3Pantoflikova D,Dorta G,Jornod P,et al.Identification of the characteristics influencing the degree of antisecretory activity of PPIs.Gastroenterology,2000,118:A1290.
4Stedman CA,Barclay ML.Comparison of the pharma cokinetics,acid suppression and efficacy of proton pump inhibitors.Aliment Pharmacol Ther,2000,14:963-978.
5Hawkey CJ,Atherton JC,Treichel HC,et al.Safety and efficacy of 7-day rabeprazole- and omeprazole-based triple therapy regimens for the eradication of Helicobacter pylori in patients with documented peptic ulcer disease.Aliment Pharmacol Ther,2003,17:1065-
6Wong BC,Wong WM,Yee YK,et al.Rabeprazole-based 3-day and 7-day triple therapy vs.omeprazole-based 7-day triple therapy for the treatment of Helicobacter pylori infection.Aliment Pharmacol Ther,2001,15:1959-1965.
